YOUR PARTNER IN ELEVATING SCIENCE
BioIVT, formerly BioreclamationIVT, is a leading global provider of high-quality biological specimens and value-added services. We specialize in control and disease state samples including human and animal tissues, cell products, blood and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples.
Our PHASEZERO Research Services team works collaboratively with clients to provide target and biomarker validation, phenotypic assays to characterize novel therapeutics, clinical assay development and in vitro hepatic modeling solutions. And as the world’s premier supplier of ADME-Tox model systems, including hepatocytes and subcellular fractions, BioIVT enables scientists to better understand the pharmacokinetics and drug metabolism of newly discovered compounds and the effects on disease processes. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE.
Learn about the new BioIVT!
BioIVT Corporate Video
VIEW OUR PRODUCTS AND SERVICES
BioIVT is a worldwide provider of human and animal biological specimens and value-added services to pharmaceutical, biotechnology, diagnostic, contract research organizations (CRO), academic and government institutions.
Looking for a Product or Service?
Our new site has over 400 individual product pages featuring the complete capabilities of BioIVT.
Visit our Request A Quote page to learn how to find your product or service of interest.
FROM THE BLOG
-
Quintuple Model Elucidates Complex Transporter-Mediated Creatinine Renal Eliminationby Steven Louie on November 20, 2018 at 5:09 pm
Transporters are membrane-bound proteins that facilitate the uptake or excretion of a wide range of compounds from nutrients, such as vitamins, to xenobiotic drugs like statins. Over the past decade, […]
-
DTCs: Straight from the Sourceby Sean Crudgington on November 7, 2018 at 6:43 pm
Accessing clinically relevant human samples can be a struggle for oncology researchers. The procurement of human biospecimens is strictly regulated in most clinical settings, thus preventing […]
-
The Rise in Respiratory Research: Increases in Disease and Illness Worldwideby arosenberg@bioivt.com (Alex Rosenberg) on September 24, 2018 at 12:00 pm
The investment in research and development activities focused on respiratory disease coincides with the rapidly increasing incidence of respiratory disease deaths. It is crucial that researchers have […]